Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Shimadzu Developing Next-generation DNA Sequencers
April 22, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 22, 2002
- MEDICAL DEVICE NEWS IN BRIEF
April 22, 2002
- Paxil's Sales Top \12 Bil. in 2001
April 22, 2002
- Meiji Seika to Promote Depromel to Non-specialists
April 22, 2002
- Hitachi Medical: Digital Ultrasound Diagnostic System
April 22, 2002
- Fujisawa Launches Protopic in Germany
April 22, 2002
- Olympus: VISERA Video System for Endoscopy
April 22, 2002
- AnGes MG Newly Agrees Agreement with Daiichi on HGF Gene Therapy
April 22, 2002
- Genzyme Promotes 4-Marker Maternal Serum Screening Test
April 22, 2002
- Nippon Roche, Chugai to Copromote Kytril
April 22, 2002
- Takeda: HICEE WHITE 2
April 22, 2002
- BUSINESS NEWS IN BRIEF
April 22, 2002
- Kyowa Hakko's Dacarbazine Approved for Hodgkin's Disease
April 15, 2002
- Ain Pharmaciez, Imagawa Yakuhin to Merge This November
April 15, 2002
- Asahi Kasei's Toledomin Shows Steady Growth in Sales
April 15, 2002
- Sugi Pharmacy: Sales Exceed \50 Bil.
April 15, 2002
- BUSINESS NEWS IN BRIEF
April 15, 2002
- OCT NEWS IN BREIF
April 15, 2002
- WEBSITE NEWS
April 15, 2002
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…